Other subjects

Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression

Mertens, L. J., Wall, M. B., Roseman, L., Demetriou, L., Nutt, D. J., & Carhart-Harris, R. L. | Journal of Psychopharmacology | 16 January 2020

A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamine

Palamar, J. J., & Acosta, P. | Clinical and Experimental | 07 January 2020

Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species

Halberstadt, A. L., Chatha, M., Klein, A. K., Wallach, J., & Brandt, S. D. | Neuropharmacology | 7 January 2020

Lysergic acid diethylamide as an analgesic agent in patients with terminal illnesses

Das, S., & Maiti, T. | PAIN MANAGEMENT | 19 December 2019

Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe

Miliano, C., Marti, M., Pintori, N., Castelli, M. P., Tirri, M., Arfè, R., & De Luca, M. A. | Frontiers in Pharmacology | 12 December 2019

Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube.

Andersson, M., & Kjellgren, A. | Harm reduction journal | 28 November 2019

Microdosing psychedelics: Motivations, subjective effects and harm reduction.

Lea, T., Amada, N., Jungaberle, H., Schecke, H., & Klein, M. | International Journal of Drug Policy | 25 November 2019

Philanthropists Fund Johns Hopkins Center for Study of Psychedelics

Rubin, R. | Jama | 31 October 2019

The ethics of psychedelic research in disorders of consciousness.

Peterson, A., Tagliazucchi, E., & Weijer, C. | Neuroscience of Consciousness | 9 October 2019

Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects

Smigielski, L., Scheidegger, M., Kometer, M., & Vollenweider, F. X. | NeuroImage | 1 August 2019

Metabolism of lysergic acid diethylamide (LSD): an update.

Libânio Osório Marta, R. F. | Drug metabolism reviews | 16 July 2019

Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.

Kuypers, K. P., Ng, L., Erritzoe, D., Knudsen, G. M., Nichols, C. D., Nichols, D. E., ... & Nutt, D. | Journal of Psychopharmacology | 14 July 2019

Psychedelic crossings: American mental health and LSD in the 1970s.

Richert, L., & Dyck, E. | Medical Humanities | 23 June 2019

REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics

Carhart-Harris, R. L., & Friston, K. J. | Pharmacological reviews | 20 June 2019

Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).

Brandt, S. D., Kavanagh, P. V., Westphal, F., Stratford, A., Elliott, S. P., Dowling, G., ... & Halberstadt, A. L. | Drug testing and analysis | 18 June 2018

Interaction of Sex and Age on the Dissociative Effects of Ketamine Action in Young Healthy Participants.

Derntl, B., Hornung, J., Sen, Z. D., Colic, L., Li, M., & Walter, M. | Frontiers in neuroscience | 18 June 2019

Collective self-experimentation in patient-led research: How online health communities foster innovation

Kempner, J., & Bailey, J. | Social Science & Medicine | 11 June 2019

Acute subjective and behavioral effects of microdoses of LSD in healthy human volunteers

Bershad, A. K., Schepers, S. T., Bremmer, M. P., Lee, R., & de Wit, H. | Biological Psychiatry | 3 June 2019

‘Never drop without your significant other, cause that way lies ruin’: The boundary work of couples who use MDMA together.

Anderson, K., Reavey, P., & Boden, Z. | International Journal of Drug Policy | 3 June 2019